Emagix has developed the first NON-INVASIVE method for EARLY detection of vascular leakage in the retina. Vascular leakage is a leading cause of blindness in diabetes and age-related macular degeneration. Vascular leakage requires urgent treatment to prevent blindness; however timely detection of leakage is challenging and involves an invasive exam with dye injection. Emagix’s AI eliminates the need for dye injection, allowing NON-INVASIVE and EARLY leakage detection.